| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8448024 | European Journal of Cancer | 2010 | 4 Pages |
Abstract
Based on these findings in patients with mild to moderate liver dysfunction no dose modifications of vinorelbine have to be taken into consideration.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jos J. Kitzen, Christian Puozzo, Maja J. de Jonge, Maud Brandely, Jaap Verweij,